Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide in Chronic Constipation
NCT07431957Phase 4Not yet recruiting
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of linaclotide in chronic idiopathic constipation (CIC), irritable bowel syndrome (IBS). Planned start Feb 2026; status: not yet recruiting.
02
Drugs
linaclotide
03
Conditions
chronic idiopathic constipation (CIC)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT07431957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07431957.